Free Trial

Innate Pharma (IPHYF) Short Interest Ratio & Short Volume

→ This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad)
Free IPHYF Stock Alerts
$2.20
0.00 (0.00%)
(As of 05/17/2024 ET)
Compare
Stock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest

Innate Pharma Short Interest Data

Current Short Interest
5,900 shares
Previous Short Interest
6,000 shares
Change Vs. Previous Month
-1.67%
Dollar Volume Sold Short
$15,635.00
Short Interest Ratio
0.0 Days to Cover
Last Record Date
April 30, 2024
Outstanding Shares
80,210,000 shares
Percentage of Shares Shorted
0.01%
Today's Trading Volume
0 shares
Average Trading Volume
1,533 shares
Today's Volume Vs. Average
0%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Innate Pharma ?

Sign up to receive the latest short interest report for Innate Pharma and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

IPHYF Short Interest Over Time

IPHYF Days to Cover Over Time

IPHYF Percentage of Float Shorted Over Time

Innate Pharma Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/20245,900 shares $15,635.00 -1.7%N/A0 $2.65
4/15/20246,000 shares $15,900.00 +3.5%N/A60 $2.65
3/31/20245,800 shares $14,964.00 No ChangeN/A29 $2.58
3/15/20245,800 shares $14,152.00 +1.8%N/A58 $2.44
2/29/20245,700 shares $16,188.00 No ChangeN/A0 $2.84
2/15/20245,700 shares $16,188.00 -5.0%N/A0 $2.84
1/15/20244,800 shares $13,632.00 +108.7%N/A48 $2.84
12/31/20232,300 shares $6,532.00 -48.9%N/A4.5 $2.84
12/15/20234,500 shares $11,475.00 +650.0%N/A22.5 $2.55
11/30/2023600 shares $1,434.00 +500.0%N/A0 $2.39
11/15/2023100 shares $239.00 No ChangeN/A1 $2.39
10/15/20239,800 shares $22,625.26 +9,700.0%N/A19.6 $2.31
9/30/2023100 shares $300.00 No ChangeN/A0 $3.00
8/31/202311,600 shares $33,698.00 +11,500.0%N/A43.5 $2.91
8/15/2023100 shares $291.00 -75.0%N/A1 $2.91
7/31/2023400 shares $1,196.00 No ChangeN/A4 $2.99
7/15/2023400 shares $1,232.00 +33.3%N/A4 $3.08
6/30/2023300 shares $1,008.00 +200.0%N/A3 $3.36
6/15/2023100 shares $334.00 -80.0%N/A0.3 $3.34
5/31/2023500 shares $1,465.00 +400.0%N/A0 $2.93
5/15/2023100 shares $293.00 -75.0%N/A1 $2.93
4/30/2023400 shares $1,152.00 +100.0%N/A4 $2.88
4/15/2023200 shares $542.00 -97.8%N/A0 $2.71
3/31/20239,200 shares $24,932.00 -27.6%N/A92 $2.71
3/15/202312,700 shares $39,497.00 +1,487.5%N/A63.5 $3.11
2/28/2023800 shares $2,344.00 +14.3%N/A8 $2.93
2/15/2023700 shares $2,408.00 -95.5%N/A0 $3.44
1/31/202315,700 shares $54,008.00 +15,600.0%N/A52.3 $3.44
1/15/2023100 shares $347.00 -97.1%N/A0.3 $3.47
12/30/20223,500 shares $11,445.00 -60.7%N/A0.7 $3.27
12/15/20228,900 shares $20,648.00 +8,800.0%N/A22.3 $2.32
11/30/2022100 shares $218.88 -90.9%N/A1 $2.19
11/15/20221,100 shares $2,519.00 -80.4%N/A1.1 $2.29
10/31/20225,600 shares $11,697.84 +30.2%N/A56 $2.09
10/15/20224,300 shares $8,901.00 +4,200.0%N/A2.3 $2.07
9/30/2022100 shares $193.00 -66.7%N/A1 $1.93
9/15/2022300 shares $780.00 -97.7%N/A1.5 $2.60
8/31/202212,800 shares $35,840.00 +236.8%N/A8.5 $2.80
8/15/20223,800 shares $10,564.00 +11.8%N/A12.7 $2.78
7/31/20223,400 shares $10,744.00 +6.3%N/A34 $3.16
What President Biden's new law means for investors (Ad)

What's Got Musk, Bezos, and Gates So Excited? Billionaires are plowing millions of dollars into a new technology that early estimates say could generate more wealth than A.I. – and determine the future of companies like Microsoft. The problem? Most investors have no idea it's happening, or how to profit on it.

This expert just went public with all the details, including which stocks to jump on immediately.
7/15/20223,200 shares $8,640.00 -3.0%N/A32 $2.70
6/30/20223,300 shares $8,580.00 -15.4%N/A1.2 $2.60
6/15/20223,900 shares $10,803.00 -54.7%N/A39 $2.77
5/31/20228,600 shares $24,338.00 +34.4%N/A86 $2.83
5/15/20226,400 shares $18,112.00 -4.5%N/A32 $2.83
4/30/20226,700 shares $18,391.50 +8.1%N/A67 $2.75
4/15/20226,200 shares $18,910.00 +51.2%N/A12.4 $3.05
3/31/20224,100 shares $14,186.00 -93.9%N/A41 $3.46
3/15/202267,000 shares $241,870.00 -10.8%N/A0 $3.61
2/28/202275,100 shares $271,111.00 +1,004.4%N/A751 $3.61
2/15/20226,800 shares $25,228.00 -70.0%N/A5.7 $3.71
1/31/202222,700 shares $85,579.00 +57.6%N/A37.8 $3.77
1/15/202214,400 shares $62,640.00 +5.1%N/A0 $4.35
12/31/202113,700 shares $59,595.00 +407.4%N/A5.1 $4.35
12/15/20212,700 shares $13,743.00 -52.6%N/A1.4 $5.09
11/30/20215,700 shares $28,618.56 +1.8%N/A6.3 $5.02
11/15/20215,600 shares $28,000.00 -51.7%N/A3.1 $5.00
10/29/202111,600 shares $65,656.00 -6.5%N/A4.1 $5.66
10/15/202112,400 shares $73,160.00 +63.2%N/A6.5 $5.90
9/30/20217,600 shares $47,500.00 -26.2%N/A0.7 $6.25
9/15/202110,300 shares $58,504.00 -94.6%N/A0.7 $5.68
8/31/2021191,300 shares $679,115.00 -49.5%N/A956.5 $3.55
8/13/2021378,500 shares $1.22 million -0.1%N/A3785 $3.22
7/30/2021378,700 shares $1.19 million +0.2%N/A3787 $3.15
7/15/2021378,100 shares $1.23 million +0.0%N/A315.1 $3.25
6/30/2021378,000 shares $1.23 million No ChangeN/A315 $3.25
6/15/2021378,000 shares $1.34 million -0.5%N/A3780 $3.55
5/28/2021379,800 shares $1.44 million -10.3%N/A0 $3.80
5/14/2021423,400 shares $1.74 million +2.3%N/A4234 $4.11
4/30/2021414,000 shares $1.85 million +3.3%N/A828 $4.48
4/15/2021400,700 shares $1.80 million +1,627.2%N/A4007 $4.48
3/31/202123,200 shares $102,506.88 -94.2%N/A77.3 $4.42
3/15/2021401,900 shares $1.82 million 0.0%N/A4019 $4.53
2/26/2021402,000 shares $1.79 million -0.1%N/A1340 $4.46
2/12/2021402,300 shares $1.94 million -0.7%N/A365.7 $4.81
1/29/2021405,200 shares $1.75 million No ChangeN/A4052 $4.33
1/15/2021405,500 shares $1.91 million 0.0%N/A1013.8 $4.72
12/31/2020405,200 shares $1.72 million -0.1%N/A368.4 $4.24
12/15/2020405,500 shares $1.77 million 0.0%N/A1013.8 $4.36
11/30/2020405,600 shares $2.21 million -0.4%N/A450.7 $5.45
11/15/2020407,100 shares $1.81 million No ChangeN/A1017.8 $4.45
10/30/2020407,100 shares $1.51 million +0.2%N/A508.9 $3.70
10/15/2020406,300 shares $1.66 million -0.1%N/A677.2 $4.08
9/30/2020406,600 shares $1.55 million -3.1%N/A4066 $3.80
9/15/2020419,700 shares $1.73 million +3.3%N/A182.5 $4.13
8/31/2020406,200 shares $2.62 million No ChangeN/A2031 $6.45
8/14/2020406,200 shares $2.62 million +0.2%N/A1354 $6.44
7/31/2020405,500 shares $2.56 million No ChangeN/A0 $6.33
7/15/2020405,500 shares $2.56 million No ChangeN/A4055 $6.33
6/30/2020405,500 shares $2.46 million +1,897.5%N/A2027.5 $6.06
What President Biden's new law means for investors (Ad)

What's Got Musk, Bezos, and Gates So Excited? Billionaires are plowing millions of dollars into a new technology that early estimates say could generate more wealth than A.I. – and determine the future of companies like Microsoft. The problem? Most investors have no idea it's happening, or how to profit on it.

This expert just went public with all the details, including which stocks to jump on immediately.
6/15/202020,300 shares $128,905.00 +0.5%N/A40.6 $6.35
5/29/202020,200 shares $125,846.00 -95.0%N/A0 $6.23
5/15/2020405,200 shares $2.86 million No ChangeN/A193 $7.07
4/30/2020405,200 shares $2.66 million No ChangeN/A4052 $6.57
4/15/2020405,200 shares $2.24 million 0.0%N/A405.2 $5.53
3/31/2020405,300 shares $2.72 million -0.6%N/A579 $6.70
3/13/2020407,900 shares $2.00 million +0.6%N/A4079 $4.90
2/28/2020405,300 shares $2.97 million -4.8%N/A4053 $7.34
2/14/2020425,900 shares $3.05 million -1.2%N/A2129.5 $7.17
1/31/2020430,900 shares $3.23 million -9.0%N/A718.2 $7.50
1/15/2020473,700 shares $3.57 million +12.0%N/A197.4 $7.53
12/31/2019422,800 shares $3.17 million -5.5%N/A325.2 $7.50

IPHYF Short Interest - Frequently Asked Questions

What is Innate Pharma's current short interest?

Short interest is the volume of Innate Pharma shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 5,900 shares of IPHYF short. Learn More on Innate Pharma's current short interest.

Is Innate Pharma's short interest increasing or decreasing?

Innate Pharma saw a drop in short interest in the month of April. As of April 30th, there was short interest totaling 5,900 shares, a drop of 1.7% from the previous total of 6,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Innate Pharma's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Innate Pharma: Cellectis S.A. (1.18%), Genfit S.A. (0.18%), X4 Pharmaceuticals, Inc. (7.85%), Cardiff Oncology, Inc. (9.88%), Elevation Oncology, Inc. (11.46%), Compugen Ltd. (2.25%), BioAtla, Inc. (11.08%), Opthea Limited (0.22%), Scilex Holding (8.38%), Zura Bio Limited (3.07%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short Innate Pharma stock?

Short selling IPHYF is an investing strategy that aims to generate trading profit from Innate Pharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Innate Pharma?

A short squeeze for Innate Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IPHYF, which in turn drives the price of the stock up even further.

How often is Innate Pharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IPHYF, twice per month. The most recent reporting period available is April, 30 2024.



More Short Interest Resources from MarketBeat

Related Companies:
Short Interest Tools:
This page (OTCMKTS:IPHYF) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
4 Cryptos BETTER than Bitcoin
True Market Insiders
Does this make you sick?
Allegiance Gold
Bill Gates is all about this tiny $2 stock
Timothy Sykes
Urgent Nvidia Warning
Altimetry
The Overlooked Retirement Asset You Probably Don’t Own
Crypto 101 Media
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
Shocking: One AI startup's revenue could surge 4,735%
Manward Press